Cited by

• The Expression of Forkhead Box P3 T Regulatory Lymphocytes as a Prognostic Factor in Malignant Melanomas.

  Gâta VA, Pașca A, Roman A, Muntean MV, Morariu DȘ, Bonci EA, Dina C, Ungureanu L. Gâta VA, et al. Int J Mol Sci. 2024 Jun 9;25(12):6377. doi: 10.3390/ijms25126377. Int J Mol Sci. 2024. PMID: 38928083 Free PMC article.
• CD4⁺FOXP3⁺ T regulatory cells decrease and CD3⁺CD8⁺ T cells recruitment in TILs from melanoma metastases after electrochemotherapy.

  Di Gennaro P, Gerlini G, Urso C, Sestini S, Brandani P, Pimpinelli N, Borgognoni L. Di Gennaro P, et al. Clin Exp Metastasis. 2016 Dec;33(8):787-798. doi: 10.1007/s10585-016-9814-x. Epub 2016 Jul 30. Clin Exp Metastasis. 2016. PMID: 27475809
• FOXP3 expression is modulated by TGF‑β1/NOTCH1 pathway in human melanoma.

  Skarmoutsou E, Bevelacqua V, D' Amico F, Russo A, Spandidos DA, Scalisi A, Malaponte G, Guarneri C. Skarmoutsou E, et al. Int J Mol Med. 2018 Jul;42(1):392-404. doi: 10.3892/ijmm.2018.3618. Epub 2018 Apr 4. Int J Mol Med. 2018. PMID: 29620159 Free PMC article.
• Electrochemotherapy of Melanoma Cutaneous Metastases in Organ Transplant Recipients: A Systematic Review of Preclinical and Clinical Studies.

  Milicevic S, Cemazar M, Ivancic AK, Gasljevic G, Bosnjak M, Sersa G, Peric B. Milicevic S, et al. Int J Mol Sci. 2023 May 6;24(9):8335. doi: 10.3390/ijms24098335. Int J Mol Sci. 2023. PMID: 37176042 Free PMC article.
• Clinical Applications and Immunological Aspects of Electroporation-Based Therapies.

  Luz JCDSD, Antunes F, Clavijo-Salomon MA, Signori E, Tessarollo NG, Strauss BE. Luz JCDSD, et al. Vaccines (Basel). 2021 Jul 2;9(7):727. doi: 10.3390/vaccines9070727. Vaccines (Basel). 2021. PMID: 34358144 Free PMC article. Review.